CRISPR Pioneers Win 2020 Nobel Prize for Chemistry
Level 5 - mechanism / opinion, no new human data
Commentary / news article with no primary empirical data
OpenAlex W3112628259 · doi:10.18502/ijph.v49i12.4800
What was done
This publication is a brief news commentary summarizing the development of programmable nucleases (meganucleases, ZFNs, TALENs, and CRISPR/Cas) and reporting on the awarding of the 2020 Nobel Prize in Chemistry to Emmanuelle Charpentier and Jennifer A. Doudna.
What was found
The abstract reports no empirical data, comparative metrics, or statistical findings. It notes that the 2020 Nobel Prize in Chemistry was awarded to Charpentier and Doudna eight years after the application of CRISPR-Cas9 for genome editing.
Why it matters
The note documents the formal recognition of CRISPR-Cas9 technology as a major breakthrough in human genome editing.
Limits
This is a non-systematic commentary containing no original experimental data, quantitative assessments of gene editing accuracy or efficiency, or clinical outcome measurements.
Cited by
- supports Oliver Smithies and Mario Capecchi received the Nobel Prize for homologous recombination decades before Jennifer Doudna and Emmanuelle Charpentier won for CRISPR.